Poly(ADP-Ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells. [electronic resource]
Producer: 20111020Description: 4944-54 p. digitalISSN:- 1538-7445
- Antimetabolites, Antineoplastic -- pharmacology
- Apoptosis -- drug effects
- Ataxia Telangiectasia Mutated Proteins
- Benzimidazoles -- pharmacology
- Cell Cycle -- drug effects
- Cell Cycle Proteins -- metabolism
- Cell Line, Tumor
- Checkpoint Kinase 1
- Checkpoint Kinase 2
- DNA Repair
- DNA-Binding Proteins -- deficiency
- Drug Synergism
- Enzyme Activation -- drug effects
- Enzyme Inhibitors -- pharmacology
- Female
- Floxuridine -- pharmacology
- Fluorouracil -- pharmacology
- Humans
- Ovarian Neoplasms -- drug therapy
- Poly (ADP-Ribose) Polymerase-1
- Poly(ADP-ribose) Polymerase Inhibitors
- Poly(ADP-ribose) Polymerases -- metabolism
- Protein Kinases -- metabolism
- Protein Serine-Threonine Kinases -- metabolism
- RNA, Small Interfering -- administration & dosage
- Transfection
- Tumor Suppressor Proteins -- metabolism
- X-ray Repair Cross Complementing Protein 1
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.